Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
Raponi S, Del Giudice I, Ilari C, Cafforio L, Messina M, Cappelli LV, Bonina S, Piciocchi A, Marinelli M, Peragine N, Mariglia P, Mauro FR, Rigolin GM, Rossi F, Bomben R, Dal Bo M, Del Poeta G, Diop F, Favini C, Rossi D, Gaidano G, Cuneo A, Gattei V, Guarini A, Foá R. Raponi S, et al. Among authors: favini c. Br J Haematol. 2019 Apr;185(1):156-159. doi: 10.1111/bjh.15405. Epub 2018 May 22. Br J Haematol. 2019. PMID: 29785734 Free article. No abstract available.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Diop F, Moia R, Favini C, Spaccarotella E, De Paoli L, Bruscaggin A, Spina V, Terzi-di-Bergamo L, Arruga F, Tarantelli C, Deambrogi C, Rasi S, Adhinaveni R, Patriarca A, Favini S, Sagiraju S, Jabangwe C, Kodipad AA, Peroni D, Mauro FR, Giudice ID, Forconi F, Cortelezzi A, Zaja F, Bomben R, Rossi FM, Visco C, Chiarenza A, Rigolin GM, Marasca R, Coscia M, Perbellini O, Tedeschi A, Laurenti L, Motta M, Donaldson D, Weir P, Mills K, Thornton P, Lawless S, Bertoni F, Poeta GD, Cuneo A, Follenzi A, Gattei V, Boldorini RL, Catherwood M, Deaglio S, Foà R, Gaidano G, Rossi D. Diop F, et al. Among authors: favini c. Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020. Haematologica. 2020. PMID: 31371416 Free PMC article.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Raponi S, Ilari C, Della Starza I, Cappelli LV, Cafforio L, Piciocchi A, Arena V, Mariglia P, Mauro FR, Gentile M, Cutrona G, Moia R, Favini C, Morabito F, Rossi D, Gaidano G, Guarini A, Del Giudice I, Foà R. Raponi S, et al. Among authors: favini c. Br J Haematol. 2020 Jun;189(5):853-859. doi: 10.1111/bjh.16434. Epub 2020 Feb 16. Br J Haematol. 2020. PMID: 32064595 Free article.
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.
Moia R, Favini C, Ferri V, Forestieri G, Terzi Di Bergamo L, Schipani M, Sagiraju S, Andorno A, Rasi S, Adhinaveni R, Talotta D, Al Essa W, De Paoli L, Margiotta Casaluci G, Patriarca A, Boldorini RL, Rossi D, Gaidano G. Moia R, et al. Among authors: favini c. Br J Haematol. 2021 Oct;195(1):108-112. doi: 10.1111/bjh.17718. Epub 2021 Jul 22. Br J Haematol. 2021. PMID: 34291829 Free PMC article.
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
Favini C, Talotta D, Almasri M, Andorno A, Rasi S, Adhinaveni R, Kogila S, Awikeh B, Schipani M, Boggione P, Mouhssine S, Ghanej J, Al Essa W, Mahmoud AM, Dondolin R, Alessa N, Margiotta Casaluci G, Boldorini R, Gattei V, Gaidano G, Moia R. Favini C, et al. Br J Haematol. 2022 Sep;198(6):1016-1022. doi: 10.1111/bjh.18352. Epub 2022 Jul 13. Br J Haematol. 2022. PMID: 35829664 Free PMC article.
Diffuse large B-cell lymphoma genotyping on the liquid biopsy.
Rossi D, Diop F, Spaccarotella E, Monti S, Zanni M, Rasi S, Deambrogi C, Spina V, Bruscaggin A, Favini C, Serra R, Ramponi A, Boldorini R, Foà R, Gaidano G. Rossi D, et al. Among authors: favini c. Blood. 2017 Apr 6;129(14):1947-1957. doi: 10.1182/blood-2016-05-719641. Epub 2017 Jan 17. Blood. 2017. PMID: 28096087 Free article. Clinical Trial.
An update on: molecular genetics of high-risk chronic lymphocytic leukemia.
Moia R, Patriarca A, Deambrogi C, Rasi S, Favini C, Kodipad AA, Schipani M, Gaidano G. Moia R, et al. Among authors: favini c. Expert Rev Hematol. 2020 Feb;13(2):109-116. doi: 10.1080/17474086.2020.1697225. Epub 2019 Nov 30. Expert Rev Hematol. 2020. PMID: 31774349 Review.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, da Silva MG, Santoro A, Molinari A, Ferreri A, Grønbæk K, Piccin A, Cortelazzo S, Bertoni F, Ladetto M, Gaidano G. Ferrero S, et al. Among authors: favini c. Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19. Haematologica. 2020. PMID: 31537689 Free PMC article. Clinical Trial.
Precision Medicine Management of Chronic Lymphocytic Leukemia.
Moia R, Patriarca A, Schipani M, Ferri V, Favini C, Sagiraju S, Al Essa W, Gaidano G. Moia R, et al. Among authors: favini c. Cancers (Basel). 2020 Mar 10;12(3):642. doi: 10.3390/cancers12030642. Cancers (Basel). 2020. PMID: 32164276 Free PMC article. Review.
12 results